SNWV Sanuwave Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SNWV

Price (delayed)

$4.705

Market cap

$40.47M

P/E Ratio

2.83

Dividend/share

N/A

EPS

$1.66

Enterprise value

$51.8M

?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 1
Relative Valuation: Rel. Valuation: 99
Relative Profitability: Rel. Profitability: 94

SANUWAVE Health, Inc. ( www.SANUWAVE.com ) is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration ...

Highlights
The equity has surged by 119% year-on-year and by 52% since the previous quarter
Sanuwave Health's debt has decreased by 26% YoY and by 7% from the previous quarter
The net income has surged by 135% year-on-year but it has declined by 8% since the previous quarter
Sanuwave Health's EPS has surged by 119% YoY but it has decreased by 8% QoQ
The quick ratio has declined by 9% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://sanuwave.com
Peers: ABT MDT BDX ISRG

Key stats

What are the main financial stats of SNWV

SNWV stock price

How has the Sanuwave Health stock price performed over time
Intraday
1.4%
1 week
11.49%
1 month
2.06%
1 year
-86.25%
YTD
-84.23%
QTD
-52.95%

Financial performance

How have Sanuwave Health's revenue and profit performed over time
Revenue
$43.9M
Gross profit
$33.48M
Operating income
$678,000
Net income
$14.31M
Gross margin
76.3%
Net margin
32.6%
The net income has surged by 135% year-on-year but it has declined by 8% since the previous quarter
Sanuwave Health's net margin has soared by 131% YoY but it has decreased by 7% from the previous quarter
Sanuwave Health's operating margin has plunged by 88% YoY and by 72% from the previous quarter
The operating income has plunged by 86% YoY and by 72% from the previous quarter

Price vs fundamentals

How does SNWV's price correlate with its fundamentals

Growth

What is Sanuwave Health's growth rate over time

Valuation

What is Sanuwave Health stock price valuation
P/E
2.83
P/B
14.52
P/S
0.92
EV/EBIT
2.88
EV/EBITDA
2.68
EV/Sales
1.18
Sanuwave Health's EPS has surged by 119% YoY but it has decreased by 8% QoQ
The equity has surged by 119% year-on-year and by 52% since the previous quarter
The stock's P/S is 81% below its last 4 quarters average of 4.7
SNWV's revenue is up by 12% YoY

Efficiency

How efficient is Sanuwave Health business performance
Sanuwave Health's return on sales has surged by 153% YoY but it has decreased by 12% QoQ
SNWV's return on assets has surged by 128% year-on-year but it is down by 10% since the previous quarter
The ROIC has contracted by 39% from the previous quarter

Dividends

What is SNWV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SNWV.

Financial health

How did Sanuwave Health financials performed over time
Sanuwave Health's total assets is 8% higher than its total liabilities
The current ratio has soared by 198% YoY but it has contracted by 2.3% from the previous quarter
Sanuwave Health's total liabilities has decreased by 29% YoY and by 4.1% from the previous quarter
The equity has surged by 119% year-on-year and by 52% since the previous quarter
The debt to equity is down by 38% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.